ClinicalTrials.govpublic full text
Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke
acute ischemic stroke, erythropoietin, carbamylated, neuroprotection, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828991
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.